Regeneron Pharmaceuticals Inc (REGN)
Cash conversion cycle
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 570.67 | 570.47 | 582.32 | 571.87 | 541.52 | 503.08 | 469.04 | 421.25 | 442.39 | 461.72 | 479.45 | 495.84 | 379.80 | 332.66 | 257.08 | 261.49 | 360.16 | 383.48 | 541.99 | 515.98 |
| Days of sales outstanding (DSO) | days | 145.69 | 144.06 | 144.10 | 159.65 | 160.98 | 154.70 | 145.50 | 157.70 | 155.63 | 147.53 | 151.04 | 159.78 | 147.71 | 132.42 | 106.99 | 137.09 | 146.94 | 206.27 | 165.60 | 176.75 |
| Number of days of payables | days | 158.49 | 128.83 | 128.69 | 146.24 | 89.23 | 98.34 | 115.98 | 99.02 | 92.66 | 100.77 | 118.54 | 121.63 | 84.33 | 80.10 | 60.71 | 75.58 | 74.88 | 92.01 | 135.93 | 128.01 |
| Cash conversion cycle | days | 557.88 | 585.70 | 597.73 | 585.28 | 613.27 | 559.44 | 498.56 | 479.93 | 505.37 | 508.48 | 511.94 | 533.99 | 443.18 | 384.97 | 303.36 | 323.00 | 432.22 | 497.74 | 571.66 | 564.71 |
September 30, 2025 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 570.67 + 145.69 – 158.49
= 557.88
Peer comparison
Sep 30, 2025
Company name
Symbol
Cash conversion cycle
Regeneron Pharmaceuticals Inc
REGN
557.88
Arrowhead Pharmaceuticals Inc
ARWR
-364.74
Biomarin Pharmaceutical Inc
BMRN
720.12
See also:
Regeneron Pharmaceuticals Inc Cash Conversion Cycle (Quarterly Data)